Shares of Atossa Therapeutics, Inc. (ATOS) stock continued the uptrend in today’s market on May 3, 2021, after gaining 0.43% at the previous closing. ATOS
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Bionano Genomics Inc. (BNGO) stock soared 13.81% to $2.39 in the pre-market trading following an announcement from the firm that Nasdaq has granted the Company
Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under
Aethlon Medical Inc. (NASDAQ: AEMD) shares are trading down -7.08% at $2.1 at the time of writing after reporting First Patient Treated in First-in-Human Clinical
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
Atossa Therapeutics, Inc. (Nasdaq: ATOS) stock dropped down -38.46 to $0.88 in the Early hour’s session today after a clinical-stage biopharmaceutical corporation looking to find
Atossa Therapeutics, Inc. (Nasdaq: ATOS) a biotech giant with a focus on breast cancer and COVID-19, today announced blinded results from its Phase 1 clinical
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.